Sacha Zeerleder

7.9k total citations · 1 hit paper
161 papers, 5.0k citations indexed

About

Sacha Zeerleder is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Sacha Zeerleder has authored 161 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Hematology, 69 papers in Immunology and 50 papers in Genetics. Recurrent topics in Sacha Zeerleder's work include Complement system in diseases (30 papers), Blood Coagulation and Thrombosis Mechanisms (29 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (28 papers). Sacha Zeerleder is often cited by papers focused on Complement system in diseases (30 papers), Blood Coagulation and Thrombosis Mechanisms (29 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (28 papers). Sacha Zeerleder collaborates with scholars based in Netherlands, Switzerland and United States. Sacha Zeerleder's co-authors include Walter A. Wuillemin, C. Erik Hack, Christoph Caliezi, C. Erik Hack, Diana Wouters, Gerben Marsman, Brenda M. Luken, Bernhard Lämmle, Erfan Nur and Maurice Redondo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Sacha Zeerleder

159 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting

2019 286 citations Sacha Zeerleder et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sacha Zeerleder Netherlands	36	1.8k	1.6k	996	936	935	161	5.0k
Zbigniew M. Szczepiorkowski United States	28	1.4k 0.8×	1.4k 0.9×	683 0.7×	768 0.8×	367 0.4×	124	4.6k
Shinichiro Okamoto Japan	41	1.1k 0.6×	3.3k 2.0×	1.1k 1.1×	1.3k 1.4×	875 0.9×	389	7.1k
Jonas Mattsson Sweden	44	2.0k 1.1×	3.7k 2.3×	635 0.6×	937 1.0×	1.0k 1.1×	326	6.4k
Bernard Bonnotte France	42	2.8k 1.6×	1.8k 1.1×	1.3k 1.3×	643 0.7×	426 0.5×	202	6.3k
Masayuki Hino Japan	34	1.1k 0.6×	1.4k 0.8×	868 0.9×	488 0.5×	587 0.6×	326	4.5k
Henrik Sengeløv Denmark	36	2.2k 1.2×	1.4k 0.9×	1.9k 1.9×	320 0.3×	713 0.8×	149	6.2k
Akio Urabe Japan	34	1.3k 0.7×	1.5k 0.9×	1.1k 1.1×	558 0.6×	582 0.6×	163	4.7k
Phillip Scheinberg United States	41	2.5k 1.4×	4.3k 2.7×	718 0.7×	1.1k 1.2×	774 0.8×	153	7.1k
Shinji Nakao Japan	49	3.0k 1.6×	3.7k 2.2×	1.4k 1.4×	1.2k 1.3×	918 1.0×	443	8.4k
Patricia C. Liaw Canada	35	1.7k 0.9×	1.1k 0.7×	1.1k 1.1×	282 0.3×	1.0k 1.1×	95	4.5k

Countries citing papers authored by Sacha Zeerleder

Since Specialization

Citations

This map shows the geographic impact of Sacha Zeerleder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sacha Zeerleder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sacha Zeerleder more than expected).

Fields of papers citing papers by Sacha Zeerleder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sacha Zeerleder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sacha Zeerleder. The network helps show where Sacha Zeerleder may publish in the future.

Co-authorship network of co-authors of Sacha Zeerleder

This figure shows the co-authorship network connecting the top 25 collaborators of Sacha Zeerleder. A scholar is included among the top collaborators of Sacha Zeerleder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sacha Zeerleder. Sacha Zeerleder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hazenberg, Mette D., Man Tang, Charlotte F.J. Van Tuijn, et al.. (2024). Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort study. American Journal of Hematology. 99(8). 1523–1531. 1 indexed citations

Wiedemann, Gertrud, Ulrike Bacher, Corinne C. Widmer, et al.. (2024). A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications. International Journal of Molecular Sciences. 25(16). 8556–8556. 1 indexed citations

Andres, Martin, Gertrud Wiedemann, Sacha Zeerleder, et al.. (2023). Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma. Hematological Oncology. 41(5). 912–921. 9 indexed citations

Baas, Inge O., Claudia C. Folman, Kyra A. Gelderman, et al.. (2023). C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia. Blood Advances. 7(13). 3128–3139. 7 indexed citations

Langereis, Jeroen D., Mieke C. Brouwer, Marlieke L.M. Jongsma, et al.. (2023). The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation. Clinical & Translational Immunology. 12(1). e1436–e1436. 16 indexed citations

Hamzeh‐Cognasse, Hind, Gerard van Mierlo, Ingrid Bulder, et al.. (2023). Platelet concentrates in platelet additive solutions generate less complement activation products during storage than platelets stored in plasma.. PubMed. 21(2). 157–167. 5 indexed citations

Hamzeh‐Cognasse, Hind, et al.. (2022). DAMPS and complement activation in platelet concentrates that induce adverse reactions in patients. Transfusion. 62(9). 1721–1726. 7 indexed citations

Mierlo, Gerard van, et al.. (2022). Plasma Exchange Therapy Using Solvent Detergent-Treated Plasma: An Observational Pilot Study on Complement, Neutrophil and Endothelial Cell Activation in a Case Series of Patients Suffering from Atypical Hemolytic Uremic Syndrome. Transfusion Medicine and Hemotherapy. 49(5). 288–297. 1 indexed citations

Novak, Urban, et al.. (2021). Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients. Cancers. 13(23). 6073–6073. 18 indexed citations

10.

Geneugelijk, Kirsten, Hanneke W. M. van Deutekom, Jorg J. A. Calis, et al.. (2019). Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations. Frontiers in Immunology. 10. 880–880. 14 indexed citations

11.

Biemond, Bart J., et al.. (2018). Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial. Trials. 19(1). 127–127. 15 indexed citations

12.

Jongsma, Marlieke L.M., et al.. (2018). CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research. Journal of Immunological Methods. 456. 15–22. 24 indexed citations

13.

Sonneveld, Myrthe E., Masja de Haas, Carolien A. M. Koeleman, et al.. (2017). Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation. Scientific Reports. 7(1). 8187–8187. 24 indexed citations

14.

Groot, Pieter F. de, Erfan Nur, Sacha Zeerleder, et al.. (2017). Fecal Microbiota Transplantation As Safe and Successful Therapy for Intestinal Graft-Versus-Host Disease. Blood. 130. 1986–1986. 7 indexed citations

15.

Balvers, Kirsten, et al.. (2016). Are there any alternatives for transfusion of AB plasma as universal donor in an emergency release setting?. Transfusion. 56(6). 1469–1474. 6 indexed citations

16.

Cortjens, Bart, Robin van Bruggen, Dirk de Korte, et al.. (2016). Transfusion of 35-Day Stored RBCs in the Presence of Endotoxemia Does Not Result in Lung Injury in Humans*. Critical Care Medicine. 44(6). e412–e419. 26 indexed citations

17.

Beer, Friso M. de, Hamid Aslami, Gerard van Mierlo, et al.. (2014). Plasma-Derived Human C1-Esterase Inhibitor Does Not Prevent Mechanical Ventilation-Induced Pulmonary Complement Activation in a Rat Model of Streptococcus pneumoniae Pneumonia. Cell Biochemistry and Biophysics. 70(2). 795–803. 4 indexed citations

18.

Zeerleder, Sacha, Femke Stephan, Marieke Emonts, et al.. (2012). Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C. Critical Care Medicine. 40(12). 3224–3229. 51 indexed citations

19.

Wouters, Diana, et al.. (2008). C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor. Expert Opinion on Biological Therapy. 8(8). 1225–1240. 35 indexed citations

20.

Zeerleder, Sacha, G Lutze, Walter‐Michael Halbmayer, et al.. (1997). Mutations in the human factor XII gene.. Blood. 90(10). 3967–77. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact